Net Income

Nearing 10% sales growth, the rice bowl chain is winning over consumers and franchisees with a potent mix of value, quality, and bold new menu items.

A new AI platform is the first to get EU approval for predicting fertility treatment timing, promising to boost success rates and ease clinic workloads.

A new driver-level verification system aims to close a critical security gap as strategic freight fraud and billion-dollar losses plague supply chains.

After settling a major legal battle, Allied Gaming is ditching its past for an ambitious—and risky—future in AI, tokenization, and a new cryptocurrency.

With 62 profitable quarters and a major new acquisition, BioSyent prepares to pitch its proven growth strategy to top healthcare investors in Toronto.

A new survey shows the Middle East conflict has shattered accountant confidence, pushing geopolitical instability and cyber threats ahead of economic fears.

The shipping firm posts a stunning $17.6M Q4 profit, reversing a major loss, thanks to a new asset management arm and a leaner, greener fleet.

With a $12B portfolio, real estate giant Lightstone is opening its private playbook to individuals via a new platform with a major co-investment pledge.

With a recidivism rate far below state averages, one nonprofit's data-driven model for reentry support is challenging traditional crime-fighting narratives.

Facing soaring costs and armed with new laws, America's largest employers are ditching old playbooks to force transparency and value from the healthcare industry.

A company named for mining is betting big on Bali's luxury villa market. But with a tiny market cap and an unknown builder, is it a brilliant pivot or a risky gamble?

The struggling footwear brand is selling its assets to become NewBird AI, a GPU provider. Is it a visionary gamble or a desperate move in the AI gold rush?

A CEO's personal battle with prostate cancer inspired a community golf tournament that is now on the verge of raising $1 million for critical research.

The pizza giant is betting big on its new Oven-Toasted Sandwiches, using a pop-up deli and its 'Better Ingredients' promise to enter a crowded market.

The world's top olive oil firm hit its 2030 recycled plastic target 5 years early, part of a sweeping sustainability push from grove to transparent bottle.

Backed by Bain Capital and a veteran team, the new biotech has a de-risked pipeline from Bristol Myers Squibb aimed at transforming care for lupus and more.

Investors eye BioCryst's May 6th report for insights into ORLADEYO's growth, a pivotal acquisition, and its strategy in the competitive rare disease market.

Scientists have created the first continent-wide map of bird flu's spread, explaining human cases and assessing the risk of a future pandemic.

Pre-rolled joints are now the #1 cannabis product by units sold, a new report reveals. Discover the strategies and innovations fueling this market takeover.

Promising early safety data for a novel drug, KM-023, brings a potential first-ever targeted treatment for the devastating Olmsted syndrome a step closer.